PRESERVE Trial: Patients with Moderately Active RA Achieve and Maintain Low Disease Activity and Remission with Anti-TNF Therapy More Successfully than Those with High Disease Activity
RitaBuckley
Medical University of Vienna, Center of Rheumatic Diseases at Hietzing Hospital, Vienna, Austria
The editors would like to thank the many members of the American College of Rheumatology 2011 Annual Meeting presenting faculty who generously gave their time to ensure the accuracy and quality of the articles in this publication.
PRESERVE Trial: Patients with Moderately Active RA Achieve and Maintain Low Disease Activity and Remission with Anti-TNF Therapy More Successfully than Those with High Disease Activity
PRESERVE Trial: Patients with Moderately Active RA Achieve and Maintain Low Disease Activity and Remission with Anti-TNF Therapy More Successfully than Those with High Disease Activity